From €3181EUR$3,500USD£2,743GBP
- Report
- July 2024
- 100 Pages
Global
From €3408EUR$3,750USD£2,939GBP
- Report
- June 2025
- 400 Pages
Global
From €4498EUR$4,949USD£3,879GBP
- Report
- June 2025
- 250 Pages
India
From €2535EUR$2,789USD£2,186GBP
- Report
- March 2023
- 141 Pages
Global
From €3271EUR$3,599USD£2,821GBP
- Report
- July 2021
- 255 Pages
Global
From €4498EUR$4,949USD£3,879GBP
- Report
- May 2025
- 100 Pages
India
From €4317EUR$4,750USD£3,723GBP
- Report
- May 2025
- 120 Pages
Asia Pacific
From €4317EUR$4,750USD£3,723GBP
- Report
- May 2025
- 105 Pages
Europe
From €4317EUR$4,750USD£3,723GBP
- Report
- May 2025
- 111 Pages
Latin America
From €4317EUR$4,750USD£3,723GBP
- Report
- September 2024
- 140 Pages
Asia Pacific
From €4317EUR$4,750USD£3,723GBP
- Report
- July 2024
- 120 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- February 2024
- 102 Pages
India
From €4317EUR$4,750USD£3,723GBP
- Report
- February 2024
- 121 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- April 2023
- 116 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- June 2025
- 208 Pages
Global
From €2272EUR$2,500USD£1,960GBP
- Report
- August 2024
- 169 Pages
Global
From €2272EUR$2,500USD£1,960GBP
- Report
- August 2024
- 172 Pages
Global
From €2272EUR$2,500USD£1,960GBP
- Report
- December 2023
- 162 Pages
Global
From €2272EUR$2,500USD£1,960GBP
- Report
- November 2024
- 65 Pages
Global
From €4540EUR$4,995USD£3,915GBP

Contract Manufacturing Organizations (CMOs) are companies that provide manufacturing services to the pharmaceutical industry. CMOs specialize in the production of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). They provide a range of services, from process development and scale-up to commercial manufacturing and packaging. CMOs are an important part of the pharmaceutical supply chain, as they enable drug companies to outsource production and focus on their core competencies.
CMOs are subject to stringent regulatory requirements, and must adhere to Good Manufacturing Practices (GMPs) to ensure the quality and safety of their products. They must also comply with the regulations of the countries in which they operate.
CMOs offer a range of advantages to drug companies, including cost savings, access to specialized expertise, and flexibility in production. They also provide a way for drug companies to quickly scale up production to meet demand.
Some of the leading CMOs in the pharmaceutical manufacturing market include Lonza, Boehringer Ingelheim, Patheon, and Recipharm. Show Less Read more